Search Within

Gopakumar Vasudeva Iyer

  1. "2021"
Formats
  1. Journal Article (17)
  2. Meeting Abstract (12)
  3. Review (3)
  4. Correspondence (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (34)
  2. Genitourinary Oncology Service (34)
  3. Solid Tumor Oncology Division (34)
  4. Department of Pathology and Laboratory Medicine (19)
  5. GSK Faculty (18)
  6. Human Oncology and Pathogenesis Program (17)

More Groups

People
  1. Jonathan Rosenberg (21)
  2. Dean Bajorin (16)
  3. David Solit (15)
  4. Hikmat Al-Ahmadie (14)
  5. Samuel Funt (11)
  6. Bernard Bochner (9)

More People

Years
  1. 2021 (34)
Publications
  1. Journal of Clinical Oncology (9)
  2. Clinical Cancer Research (4)
  3. Advances in Anatomic Pathology (2)
  4. Bladder Cancer (1)
  5. British Journal of Cancer (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (5)
  3. Elsevier Inc. (3)
  4. Lippincott Williams & Wilkins (3)
  5. Nature Publishing Group (3)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD274 (PD-L1) copy number changes (gain) & response to immune checkpoint blockade therapy in carcinomas of the urinary tract
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Zhang, Y.; Tickoo, S. K.; Fine, S. W.; Gopalan, A.; Chen, Y. B.; Sirintrapun, S. J.; Teo, M. Y.; Funt, S. A.; more...
    Bladder Cancer (2021)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of extracellular signal-regulated kinase inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Canestraro, J.; Haggag-Lindgren, D.; Harding, J. J.; Diamond, E. L.; Drilon, A.; Li, B. T.; Iyer, G.; Schram, A. M.; Abramson, D. H.
    Ophthalmology Retina (2021)

    Fulltext@MSK | Save
  • Preliminary results of molecular screening for FGFR alterations (alts) in the RAGNAR histology-agnostic study with the FGFR-inhibitor (FGFRi) erdafitinib
    Meeting Abstract

    Massard, C.; Pant, S.; Iyer, G.; Schuler, M. H.; Witt, O.; Qin, S.; Tabernero, J.; Doi, T.; Hargrave, D. R.; Hammond, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab (A) with gemcitabine and cisplatin (GC) in patients (pts) with muscle-invasive bladder cancer (MIBC): A multicenter, single-arm, phase 2 trial
    Meeting Abstract

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H. A.; Quinlan, C.; Teo, M. Y.; Kamradt, J.; Khalil, M. F.; Ostrovnaya, I.; McCoy, A. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Institutional experience with nab-sirolimus in patients with malignancies harboring TSC1 or TSC2 mutations
    Meeting Abstract

    Dickson, M. A.; Ravi, V.; Ganjoo, K. N.; Iyer, G.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of cancer-specific microbiome signature of response to immune checkpoint inhibitors
    Meeting Abstract

    Sarfaty, M.; Desjardins, C. A.; Giardina, P.; Bardhan, K.; Pandian, S.; Halley, K.; Halvorsen, E. M.; Callahan, M. K.; Postow, M. A.; Lee, C. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy
    Meeting Abstract

    Sarfaty, M.; Teo, M. Y.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Ratna, N.; Regazzi, A. M.; Lenis, A. T.; Chen, Z.; Al-Ahmadie, H. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience
    Meeting Abstract

    Guercio, B. J.; Gandhi, J.; Teo, M. Y.; Lattanzi, M.; Funt, S. A.; Aggen, D. H.; Chen, Y. B.; Fine, S.; Pietzak, E. J.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of fibroblast growth factor receptor inhibitor-associated retinopathy
    Journal Article

    Francis, J. H.; Harding, J. J.; Schram, A. M.; Canestraro, J.; Haggag-Lindgren, D.; Heinemann, M.; Kriplani, A.; Jhaveri, K.; Voss, M. H.; Bajorin, D.; more...
    JAMA Ophthalmology (2021)

    Fulltext@MSK | Save
  • LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
    Journal Article

    Shen, R.; Postow, M. A.; Adamow, M.; Arora, A.; Hannum, M.; Maher, C.; Wong, P.; Curran, M. A.; Hollmann, T. J.; Jia, L.; more...
    Science Translational Medicine (2021)

    Fulltext@MSK | Save